Braun Stacey Associates Inc Abb Vie Inc. Transaction History

Braun Stacey Associates Inc

$2.54 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$154.79 - $180.76 $766,055 - $894,581	4,949 New	4,949 $848,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $1.35 Million - $1.62 Million	-9,773 Reduced 11.7%	73,762 $11.9 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $2.4 Million - $2.76 Million	-17,911 Reduced 17.66%	83,535 $11.2 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $3.17 Million - $4.03 Million	-23,058 Reduced 18.52%	101,446 $15.5 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $1.56 Million - $1.93 Million	-11,815 Reduced 8.67%	124,504 $20.2 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $223,669 - $283,006	2,082 Added 1.55%	136,319 $18.5 Million
Q3 2021 Dec 01, 2021	SELL	$106.4 - $120.78 $462,520 - $525,030	-4,347 Reduced 3.14%	134,237 $14.5 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $55,235 - $61,535	525 Added 0.38%	138,584 $15.6 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $414,110 - $455,885	4,048 Added 3.02%	138,059 $14.9 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $2.03 Million - $2.74 Million	25,174 Added 23.13%	134,011 $14.4 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $251,888 - $295,633	2,932 Added 2.77%	108,837 $9.53 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $5.17 Million - $6.91 Million	70,420 Added 198.45%	105,905 $10.4 Million
Q1 2020 Jun 09, 2020	SELL	$64.5 - $97.79 $58,050 - $88,011	-900 Reduced 2.47%	35,485 $2.7 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $2.62 Million - $3.28 Million	36,385 New	36,385 $3.22 Million
Q2 2019 Jul 25, 2019	SELL	$65.7 - $83.98 $285,138 - $364,473	-4,340 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $2.32 Million - $2.73 Million	-30,035 Reduced 87.37%	4,340 $350,000
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $6.17 Million - $7.61 Million	-79,301 Reduced 69.76%	34,375 $3.17 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $1.44 Million - $1.6 Million	-16,196 Reduced 12.47%	113,676 $10.8 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $335,058 - $396,450	3,732 Added 2.96%	129,872 $12 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $68,363 - $91,545	-743 Reduced 0.59%	126,140 $11.9 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $7.6 Million - $8.34 Million	84,908 Added 202.28%	126,883 $12.3 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $2.93 Million - $3.75 Million	41,975	41,975 $3.73 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Account